These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4692859)

  • 1. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG.
    Mardiney MR; Ungaro PC; Drake WP
    Natl Cancer Inst Monogr; 1973 Dec; 39():89-90. PubMed ID: 4595329
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion paper: effect of hemolytic streptococci on lymphocytic leukemia in AKR mice.
    Havas HF
    Ann N Y Acad Sci; 1976; 277(00):299-301. PubMed ID: 1069550
    [No Abstract]   [Full Text] [Related]  

  • 4. Active immunotherapy of AkR mice spontaneous leukemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
    Drake WP; Cimino EF; Mardiney MR; Sutherland JC
    J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of spontaneous AKR leukemia by multiple inoculations of Corynebacterium parvum.
    Check JH; Silverman GA; Dryden RL; Brady LW
    Cancer; 1979 Aug; 44(2):488-91. PubMed ID: 476565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-leukaemic AkR mice are not tolerant to cells of leukaemia induced by Gross virus.
    Doré JF; Ajuria E; Mathé G
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):81-4. PubMed ID: 5442690
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of active specific and non-specific immunotherapy on E male G2 leukemia according to the route of administration and combination of immunological stimulants.
    Amiel JL; Bĕrardet M
    Eur J Cancer (1965); 1971 Oct; 7(5):419-23. PubMed ID: 5159873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of B.C.G. on the hepatic catalase activity in mouse. Relation between the reticuloendothelial system and the resistance against grafted AKR leukemia].
    Lamensans A; Mollier MF; Laurent M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):871-6. PubMed ID: 4885127
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
    Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
    J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Life prolongation in AKR mice through BCG vaccination].
    Blau HJ
    Dtsch Gesundheitsw; 1972 Jul; 27(28):1336-7. PubMed ID: 5052561
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of spontaneous leukemia in germfree AKR.
    Pollard M; Sharon N
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1494-7. PubMed ID: 5138479
    [No Abstract]   [Full Text] [Related]  

  • 16. Active immunotherapy in spontaneous leukemia of AkR mice.
    Mathé G; Halle-Pannenko O; Bourut C
    Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative behavior of eosinophilic granulocytes in BCG-vaccinated and nonvaccinated AKR mice and A mice].
    Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):263-71. PubMed ID: 4123090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oncological characteristics of AKR/JY mice].
    Khar'kovskaia NA; Khrustalev SA
    Eksp Onkol; 1984; 6(4):62-6. PubMed ID: 6548693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pyogenes preparation OK-432: immunoprophylactic and immunotherapeutic effects on the incidence of spontaneous leukemia in AKR mice.
    Aoki T; Kvedar JP; Hollis VW; Bushar GS
    J Natl Cancer Inst; 1976 Mar; 56(3):687-90. PubMed ID: 56450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic and therapeutic application of interferon in spontaneous leukemia in AKR mice.
    Bekesi JG; Roboz JP
    Tex Rep Biol Med; 1981-1982; 41():614-20. PubMed ID: 6189228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.